HRT Financial’s Amphastar Pharmaceuticals AMPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.82M Buy
387,530
+331,349
+590% +$6.68M 0.01% 896
2026
Q1
$1.1M Buy
+56,181
New +$1.37M ﹤0.01% 1998
2025
Q4
Sell
-77,746
Closed -$2.07M 3125
2025
Q3
$2.07M Buy
77,746
+35,666
+85% +$921K 0.01% 1130
2025
Q2
$966K Sell
42,080
-44,284
-51% -$1.1M ﹤0.01% 1283
2025
Q1
$2.5M Buy
+86,364
New +$2.76M 0.02% 720
2024
Q2
Sell
-18,608
Closed -$817K 2168
2024
Q1
$817K Buy
+18,608
New +$961K 0.01% 983
2023
Q4
Sell
-10,057
Closed -$462K 2272
2023
Q3
$462K Buy
10,057
+4,028
+67% +$220K ﹤0.01% 1447
2023
Q2
$346K Sell
6,029
-25,918
-81% -$1.15M ﹤0.01% 1541
2023
Q1
$1.2M Buy
31,947
+14,254
+81% +$467K 0.01% 859
2022
Q4
$495K Buy
+17,693
New +$514K 0.01% 1433
2022
Q3
Sell
-12,340
Closed -$429K 2745
2022
Q2
$429K Buy
+12,340
New +$440K ﹤0.01% 1780
2021
Q4
Sell
-14,315
Closed -$272K 3120
2021
Q3
$272K Sell
14,315
-21,733
-60% -$426K ﹤0.01% 2474
2021
Q2
$726K Buy
+36,048
New +$679K 0.01% 1450
2020
Q3
Sell
-11,654
Closed -$261K 1863
2020
Q2
$261K Buy
+11,654
New +$213K 0.01% 1044

Other funds holding AMPH

HRT Financial's AMPH Position: Q2 2026 in Review

HRT Financial increased its Amphastar Pharmaceuticals (AMPH) stake by 590% in Q2 2026, buying an estimated $6.68M and bringing the position to 387,530 shares worth $7.82M. The position accounts for 0.01% of the portfolio, ranked #896.

HRT Financial first reported a position in AMPH in Q2 2020 and has held it in 14 quarters since. 212 funds tracked by Wall St. Rank hold AMPH as of Q2 2026.

  • HRT Financial held 387,530 shares of Amphastar Pharmaceuticals worth $7.82M as of Q2 2026.
  • HRT Financial bought 331,349 Amphastar Pharmaceuticals shares in Q2 2026, an estimated $6.68M.
  • Amphastar Pharmaceuticals made up 0.01% of HRT Financial's portfolio in Q2 2026, its #896 holding.
  • HRT Financial first reported a position in Amphastar Pharmaceuticals in Q2 2020 and has held it in 14 quarters since.
  • 212 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.